(Q47576107)

English

Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction

scientific article published in July 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22734512

Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction (English)

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22734512

1 reference

ChEBI release 2020-05-28

author name string

James I Gillespie

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22734512

Stefano Palea

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22734512

Veronique Guilloteau

3

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22734512

Marc Guerard

4

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22734512

Philippe Lluel

5

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22734512

Cees Korstanje

6

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22734512

publication date

1 July 2012

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22734512

BJU International

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22734512

110

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22734512

2 Pt 2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22734512

E132-42

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22734512

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

Overactive bladder symptoms: do we need urodynamics?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

The effect of cromakalim on the normal and hyper-reflexic human detrusor muscle.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

Neural control of the lower urinary and gastrointestinal tracts: supraspinal CNS mechanisms.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

Relaxant effects of isoproterenol and selective beta3-adrenoceptor agonists on normal, low compliant and hyperreflexic human bladders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

Effects of beta(3)-adrenoceptor stimulation on prostaglandin E(2)-induced bladder hyperactivity and on the cardiovascular system in conscious rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

Effect of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

Phasic non-micturition contractions in the bladder of the anaesthetized and awake rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

Urine storage mechanisms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

The autonomous bladder: a view of the origin of bladder overactivity and sensory urge

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

On the origins of the sensory output from the bladder: the concept of afferent noise

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

Ambulatory urodynamics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

The neural control of micturition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

Noradrenaline inhibits autonomous activity in the isolated guinea pig bladder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

Damage to the bladder neck alters autonomous activity and its sensitivity to cholinergic agonists

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

Effects of CL316,243, a beta 3-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11240.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2012.11240.X

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22734512

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22734512

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47576107&oldid=2160565495"